who manufactures glp 1 drugs What to know about the new era of GLP-1 List of GLP-1 Receptor Agonists
Description
Ans: Ozempic dominated with approximately 35.12% share in 2025
Parenteral administration, which includes subcutaneous injections, is the most common route for GLP-1 receptor agonists
10.1016/j.cbi.2020.108968 [DOI] [PubMed] [Google Scholar] 52.Bliddal H, Bays H, Czernichow S, Udden Hemmingsson J, Hjelmesaeth J, Hoffmann Morville T, Koroleva A, Skov Neergaard J, Velez Sanchez P, Wharton S, Wizert A, Kristensen LE, Group SS (2024) Once-weekly semaglutide in persons with obesity and knee osteoarthritis
Unexplored weight management metrics
Orskov C, and Poulsen SS
